ALK Inhibitors for ALK+ NSCLC - 2025 Targeted Therapies in Lung Cancer Patient Forum скачать в хорошем качестве

ALK Inhibitors for ALK+ NSCLC - 2025 Targeted Therapies in Lung Cancer Patient Forum

The 2025 Targeted Therapies in Lung Cancer Patient Forum was a live, virtual, interactive patient education event presented in March 2025 and led by Dr. Lyudmila Bazhenova. It included presentations and panel discussions from 11 top medical professionals covering educational topics related to molecular targets in lung cancer as well as an opportunity to ask questions of the experts in multiple Q&A sessions. The speakers presented patient-focused discussions to educate the patient and caregiver communities to become advocates for their own health and well-being. In this video, Dr. Bestvina discusses the development of ALK inhibitors over the years and the evolution of first and next-generation ALK inhibitors for ALK+ non-small cell lung cancer (NSCLC). For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Music: Creative Minds (BenSound) License: WLVYBP2ARGGSGUQQ